Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025

4/26/24 7:29:36 AM ET

Medical/Dental Instruments

Health Care

Get the next $BTCY alert in real time by email

Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Customers Placing Pre-orders For The Next Run, Which Is Scheduled To Ship To Customers By End Of May.

Get the next $BTCY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BTCY

Date	Price Target	Rating	Analyst
11/20/2023		Buy → Neutral	H.C. Wainwright
3/7/2022	$5.00	Buy	Lake Street
11/23/2021	$6.00	Buy	HC Wainwright & Co.

More analyst ratings

$BTCY
Press Releases

Fastest customizable press release news feed in the world

SWK Holdings Provides Portfolio Update
Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results
10/17/24 4:15:00 PM ET
$BTCY
$DERM
$ELUT
$ETON
Medical/Dental Instruments
Health Care
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 / Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company that is reshaping the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today reports compelling financial and strategic advancements that will propel the company towards profitability by the end of Fiscal Q4. Biotricity is now on an accelerated trajectory to profitability due to growing revenues from sales and strategic partnerships, improving margins, and an earlier than expected milestone of achieving EBITDA positive on a go-forward cash b
10/3/24 8:15:00 AM ET
$BTCY
Medical/Dental Instruments
Health Care
Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States
REDWOOD CITY, CA / ACCESSWIRE / September 26, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting-edge remote monitoring and diagnostic solutions, announces its inclusion as a supplier to another major medical system that encompasses 60,000 care providers over 400 hospitals and 400 care centers. In the U.S. today, 121.5 million adults have some form of cardiovascular disease. Yet nearly half of U.S. counties do not have a practicing cardiologist, leaving patients in these areas with a roundtrip of over 85 miles to see a heart specialist versus 16 miles for those in a county with at least 1 cardiologist.
9/26/24 8:15:00 AM ET
$BTCY
Medical/Dental Instruments
Health Care

$BTCY
Financials

Live finance-specific insights

SWK Holdings Provides Portfolio Update
Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results
10/17/24 4:15:00 PM ET
$BTCY
$DERM
$ELUT
$ETON
Medical/Dental Instruments
Health Care
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 / Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company that is reshaping the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today reports compelling financial and strategic advancements that will propel the company towards profitability by the end of Fiscal Q4. Biotricity is now on an accelerated trajectory to profitability due to growing revenues from sales and strategic partnerships, improving margins, and an earlier than expected milestone of achieving EBITDA positive on a go-forward cash b
10/3/24 8:15:00 AM ET
$BTCY
Medical/Dental Instruments
Health Care
Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States
REDWOOD CITY, CA / ACCESSWIRE / September 26, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting-edge remote monitoring and diagnostic solutions, announces its inclusion as a supplier to another major medical system that encompasses 60,000 care providers over 400 hospitals and 400 care centers. In the U.S. today, 121.5 million adults have some form of cardiovascular disease. Yet nearly half of U.S. counties do not have a practicing cardiologist, leaving patients in these areas with a roundtrip of over 85 miles to see a heart specialist versus 16 miles for those in a county with at least 1 cardiologist.
9/26/24 8:15:00 AM ET
$BTCY
Medical/Dental Instruments
Health Care

Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025

Chat with this insight

Recent Analyst Ratings for
$BTCY

$BTCY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Rosa David A

SEC Form 4 filed by Al-Siddiq Waqaas

SEC Form 4 filed by Ayanoglou John

$BTCY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Biotricity downgraded by H.C. Wainwright

Lake Street initiated coverage on Biotricity with a new price target

HC Wainwright & Co. initiated coverage on Biotricity with a new price target

$BTCY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Biotricity Inc.

$BTCY
SEC Filings

$BTCY
Market Insights

Live Market Insights

SEC Form 25-NSE filed by Biotricity Inc.

SEC Form 10-Q filed by Biotricity Inc.

Biotricity Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

Biotricity's AI Cloud Upgrades Drive Operational Gains and Path to Profitability

Biotricity shares are trading higher after the company announced that it expects to reach a milestone of being EBITDA positive.

Reported Earlier, Biotricity Now Expects To Reach Milestone Of Being EBITDA Positive Before The End Of Calendar 2024

$BTCY
Press Releases

Fastest customizable press release news feed in the world

SWK Holdings Provides Portfolio Update

Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

$BTCY
Financials

Live finance-specific insights

SWK Holdings Provides Portfolio Update

Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025

Chat with this insight

Recent Analyst Ratings for $BTCY

$BTCY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Rosa David A

SEC Form 4 filed by Al-Siddiq Waqaas

SEC Form 4 filed by Ayanoglou John

$BTCY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Biotricity downgraded by H.C. Wainwright

Lake Street initiated coverage on Biotricity with a new price target

HC Wainwright & Co. initiated coverage on Biotricity with a new price target

$BTCY Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Biotricity Inc.

$BTCY SEC Filings

$BTCY Market Insights

Live Market Insights

SEC Form 25-NSE filed by Biotricity Inc.

SEC Form 10-Q filed by Biotricity Inc.

Biotricity Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

Biotricity's AI Cloud Upgrades Drive Operational Gains and Path to Profitability

Biotricity shares are trading higher after the company announced that it expects to reach a milestone of being EBITDA positive.

Reported Earlier, Biotricity Now Expects To Reach Milestone Of Being EBITDA Positive Before The End Of Calendar 2024

$BTCY Press Releases

Fastest customizable press release news feed in the world

SWK Holdings Provides Portfolio Update

Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

$BTCY Financials

Live finance-specific insights

SWK Holdings Provides Portfolio Update

Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

Recent Analyst Ratings for
$BTCY

$BTCY
Insider Trading

$BTCY
Analyst Ratings

$BTCY
Large Ownership Changes

$BTCY
SEC Filings

$BTCY
Market Insights

$BTCY
Press Releases

$BTCY
Financials